Literature DB >> 15510940

Non-typhoidal salmonella bacteraemia--an under-recognized feature of AIDS in African adults.

Anstead M Kankwatira1, Gershom A K Mwafulirwa, Melita A Gordon.   

Abstract

Non-typhoidal salmonella (NTS) infections are severe, invasive and recurrent in the HIV-infected adult, and NTS are the commonest cause of hospital admission with bacteraemia in sub-Saharan Africa. NTS bacteraemia typically presents in patients with HIV/AIDS once the CD4 count falls below 200 cells/microL. In-patient mortality is 35%-60%, and is highest in patients with confusion or severe anaemia. Among survivors, 25%-45% may have single or multiple recurrences of NTS bacteraemia 1-6 months after the first illness, requiring retreatment. Diagnosis relies on blood culture, so in many areas this disease cannot be definitively diagnosed, and must be empirically treated. Treatment is guided by local antibiotic sensitivities; fluoroquinolones are particularly useful for initial treatment if there is multidrug reistance to other agents, and may result in lower recurrence rates than other agents. Where possible, long-term secondary chemoprophylaxis to prevent recurrence is advisable. Successful ARV treatment also prevents recurrence. There is inadequate knowledge about the epidemiology of carriage and transmission among at-risk populations.

Entities:  

Mesh:

Year:  2004        PMID: 15510940     DOI: 10.1177/004947550403400404

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  21 in total

Review 1.  Innate immune response in the gut against Salmonella - review.

Authors:  I Trebichavský; I Splíchal; A Splíchalová
Journal:  Folia Microbiol (Praha)       Date:  2010-06-06       Impact factor: 2.099

Review 2.  Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis.

Authors:  Manuela Raffatellu; Daniela Chessa; R Paul Wilson; Cagla Tükel; Mustafa Akçelik; Andreas J Bäumler
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 3.  Phagocytic activity in human immunodeficiency virus type 1 infection.

Authors:  Agostino Pugliese; Valerio Vidotto; Tiziana Beltramo; Donato Torre
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

Review 4.  Salmonella: from pathogenesis to therapeutics.

Authors:  Erin C Boyle; Jennifer L Bishop; Guntram A Grassl; B Brett Finlay
Journal:  J Bacteriol       Date:  2006-12-22       Impact factor: 3.490

Review 5.  A dynamic view of the spread and intracellular distribution of Salmonella enterica.

Authors:  Pietro Mastroeni; Andrew Grant; Olivier Restif; Duncan Maskell
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

6.  Microbiological analysis of nontyphoidal Salmonella strains causing distinct syndromes of bacteremia or enteritis in HIV/AIDS patients in San Diego, California.

Authors:  Michael J Preziosi; Sean M Kandel; Donald G Guiney; Sara H Browne
Journal:  J Clin Microbiol       Date:  2012-08-29       Impact factor: 5.948

7.  Structural and functional characterization of three DsbA paralogues from Salmonella enterica serovar typhimurium.

Authors:  Begoña Heras; Makrina Totsika; Russell Jarrott; Stephen R Shouldice; Gregor Guncar; Maud E S Achard; Timothy J Wells; M Pilar Argente; Alastair G McEwan; Mark A Schembri
Journal:  J Biol Chem       Date:  2010-03-16       Impact factor: 5.157

8.  Systemic CD8 T-cell memory response to a Salmonella pathogenicity island 2 effector is restricted to Salmonella enterica encountered in the gastrointestinal mucosa.

Authors:  Jessica Jones-Carson; Bruce D McCollister; Eric T Clambey; Andrés Vázquez-Torres
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

9.  Fatal dual infection with Salmonella and Mycobacterium avium complex infection in a patient with advanced acquired immunodeficiency syndrome: a case report.

Authors:  Adetunji Adejumo; Olutayo Olabige; Vel Sivapalan
Journal:  Cases J       Date:  2009-09-11

10.  Virulent Salmonella enterica infections can be exacerbated by concomitant infection of the host with a live attenuated S. enterica vaccine via Toll-like receptor 4-dependent interleukin-10 production with the involvement of both TRIF and MyD88.

Authors:  Gemma L Foster; Tom A Barr; Andrew J Grant; Trevelyan J McKinley; Clare E Bryant; Andrew MacDonald; David Gray; Masahiro Yamamoto; Shizuo Akira; Duncan J Maskell; Pietro Mastroeni
Journal:  Immunology       Date:  2008-02-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.